Clinical Trial

Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis

Name: Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis — clinical trial record (NCT07525427)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate if TBD09 in combination with other active agents in adults with drug sensitive pulmonary tuberculosis has potential to be safe and effective.

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-01

Trial Details

NCT Number	NCT07525427
Lead Sponsor	Gates Medical Research Institute Collaborators: IQVIA RDS Inc.
Conditions	Drug Susceptible Pulmonary Tuberculosis
Enrollment	150 participants
Start Date	2026-04-14
Primary Completion	2026-11-05 (estimated)
Study Completion	2026-11-05 (estimated)
Updated on ClinicalTrials.gov	2026-07-30